Tudor Investment Corp
CTIC

Tudor Investment Corp’s CTI BioPharma Corp. (DE) Common Stock CTIC Stock Holding History

Tudor Investment Corp’s Portfolio CTIC Stock Details CTIC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q2 		– Sell
-25,000
Closed -$98K – 1363
2018
Q1 		$98K Buy
+25,000
New +$87.9K ﹤0.01% 923
2016
Q2 		– Sell
-18,850
Closed -$100K – 2178
2016
Q1 		$100K Buy
+18,850
New +$151K ﹤0.01% 1617
2015
Q3 		– Sell
-6,860
Closed -$134K – 1944
2015
Q2 		$134K Sell
6,860
-1,830
-21% -$35.3K ﹤0.01% 1388
2015
Q1 		$157K Buy
+8,690
New +$196K 0.01% 1334

Other funds holding CTIC

BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
O
OrbiMed New York $4.59B AUM 125.28% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $114M AUM 77.6% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $408M AUM 318.81% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
SFM
Sphera Funds Management Tel Aviv, Israel $581M AUM 108.65% 1-Year Est. Return